BlueCrest Capital Management’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,250	Closed	-$129K	–	490
2019 Q1	$129K	Buy	+6,250	New	+$129K	0.01%	1027